CDX-2401

Prevention and Treatment of AIDS

Celldex is working with a team of researchers led by Rockefeller University immunologist Ralph M. Steinman, M.D., to develop a novel vaccine against HIV, the virus known to cause AIDS. This project is supported through a $14 million grant from the Grand Challenges for Global Health program within the Bill & Melinda Gates Foundation. The project utilizes Celldex’s human antibodies to DEC-205 receptors on dendritic cell to selectively initiate robust immune responses against specifically selected HIV antigens.